MediPharm Labs Corp. (LABS:TSX) closed at $0.065 on October 23, 2026, unchanged on the day. The stock trades 35.0% below its 52-week high of $0.100 and 8.3% above its 52-week low of $0.060. Over the past year, it lost 13.3%. MediPharm Labs Corp. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, LABS closed higher on 45 days (18%). Its best day was April 28, 2026 (+20.00%) and its worst was July 17, 2026 (-13.33%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 12 times.
MediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good Manufacturing Practices and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to produce purified, pharmaceutical-grade cannabis oil and concentrates for derivative products. The company has invested in the research-driven team, technology, downstream extraction methodologies and purpose-built facilities to deliver safe and precisely-dosed cannabis products to patients and consumers.
Find more stocks like LABS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.